Distinct disruptions in Land's cycle remodeling of glycerophosphocholines in murine cortex mark symptomatic onset and progression in two Alzheimer's disease mouse models

被引:18
作者
Granger, Matthew W. [1 ,2 ]
Liu, Hui [3 ]
Fowler, Caitlin F. [1 ,2 ]
Blanchard, Alexandre P. [1 ,2 ]
Taylor, Matthew W. [1 ,2 ]
Sherman, Samantha P. M. [1 ,2 ]
Xu, Hongbin [1 ,2 ]
Le, Weidong [3 ,4 ]
Bennett, Steffany A. L. [1 ,2 ]
机构
[1] Univ Ottawa, Brain & Mind Res Inst, Ctr Catalysis Res & Innovat, Neural Regenerat Lab,Ottawa Inst Syst Biol, Ottawa, ON, Canada
[2] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada
[3] Fudan Univ, Zhongshan Hosp, Minhang Branch, Dept Neurol, Shanghai, Peoples R China
[4] Dailan Med Univ, Affiliated Hosp 1, Ctr Clin Res Neurol Dis, Dailan 116021, Peoples R China
基金
芬兰科学院;
关键词
Alzheimer's disease; glycerophosphocholine; hypoxia; lipidomics; phospholipase A(2); platelet-activating factor; PLATELET-ACTIVATING-FACTOR; PHOSPHOLIPASE A(2) ACTIVITY; CEREBROSPINAL-FLUID; COGNITIVE IMPAIRMENT; NEUROFIBRILLARY TANGLES; AMYLOID DEPOSITION; HYPOXIA; BRAIN; TAU; VISUALIZATION;
D O I
10.1111/jnc.14560
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Changes in glycerophosphocholine metabolism are observed in Alzheimer's disease; however, it is not known whether these metabolic disruptions are linked to cognitive decline. Here, using unbiased lipidomic approaches and direct biochemical assessments, we profiled Land's cycle lipid remodeling in the hippocampus, frontal cortex, and temporal-parietal-entorhinal cortices of human amyloid beta precursor protein (Alpha beta PP) over-expressing mice. We identified a cortex-specific hypo-metabolic signature at symptomatic onset and a cortex-specific hyper-metabolic signature of Land's cycle glycerophosphocholine remodeling over the course of progressive behavioral decline. When N5 TgCRND8 and Alpha beta PPSwe/PSIdE9 mice first exhibited deficits in the Morris Water Maze, levels of lyso-phosphatidylcholines, LPC(18:0/0:0), LPC(16:0/0:0), LPC(24:6/0:0), LPC(25:6/0:0), the lyso-platelet-activating factor (PAF), LPC(O-18:0/0:0), and the PAF, PC(O-22:6/2:0), declined as a result of reduced calcium-dependent cytosolic phospholipase A(2)alpha (cPLA(2)alpha) activity in all cortices but not hippocampus. Chronic intermittent hypoxia, an environmental risk factor that triggers earlier learning memory impairment in Alpha beta PPSwe/PSIdE9 mice, elicited these same metabolic changes in younger animals. Thus, this lipidomic signature of phenoconversion appears age-independent. By contrast, in symptomatic N5 TgCRND8 mice, cPLA(2)alpha activity progressively increased; overall Lyso-phosphatidylcholines (LPC) and LPC(O) and PC(O-18:1/2:0) levels progressively rose. Enhanced cPLA(2)alpha activity was only detected in transgenic mice; however, age-dependent increases in the PAF acetylhydrolase 1b alpha(1) to alpha(2) expression ratio, evident in both transgenic and non-transgenic mice, reduced PAF hydrolysis thereby contributing to PAF accumulation. Taken together, these data identify distinct age-independent and age-dependent disruptions in Land's cycle metabolism linked to symptomatic onset and progressive behavioral decline in animals with pre-existing Alpha beta pathology. Open science badges This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at .
引用
收藏
页码:499 / 517
页数:19
相关论文
共 62 条
  • [1] Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
    Bateman, Randall J.
    Xiong, Chengjie
    Benzinger, Tammie L. S.
    Fagan, Anne M.
    Goate, Alison
    Fox, Nick C.
    Marcus, Daniel S.
    Cairns, Nigel J.
    Xie, Xianyun
    Blazey, Tyler M.
    Holtzman, David M.
    Santacruz, Anna
    Buckles, Virginia
    Oliver, Angela
    Moulder, Krista
    Aisen, Paul S.
    Ghetti, Bernardino
    Klunk, William E.
    McDade, Eric
    Martins, Ralph N.
    Masters, Colin L.
    Mayeux, Richard
    Ringman, John M.
    Rossor, Martin N.
    Schofield, Peter R.
    Sperling, Reisa A.
    Salloway, Stephen
    Morris, John C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) : 795 - 804
  • [2] Adaptive linear step-up procedures that control the false discovery rate
    Benjamini, Yoav
    Krieger, Abba M.
    Yekutieli, Daniel
    [J]. BIOMETRIKA, 2006, 93 (03) : 491 - 507
  • [3] Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease
    Bennett, Steffany A. L.
    Valenzuela, Nicolas
    Xu, Hongbin
    Franko, Bettina
    Fai, Stephen
    Figeys, Daniel
    [J]. FRONTIERS IN PHYSIOLOGY, 2013, 4
  • [4] NEOCORTICAL NEUROFIBRILLARY TANGLES CORRELATE WITH DEMENTIA SEVERITY IN ALZHEIMERS-DISEASE
    BIERER, LM
    HOF, PR
    PUROHIT, DP
    CARLIN, L
    SCHMEIDLER, J
    DAVIS, KL
    PERL, DP
    [J]. ARCHIVES OF NEUROLOGY, 1995, 52 (01) : 81 - 88
  • [5] Visualization and Phospholipid Identification (VaLID): online integrated search engine capable of identifying and visualizing glycerophospholipids with given mass
    Blanchard, Alexandre P.
    McDowell, Graeme S. V.
    Valenzuela, Nico
    Xu, Hongbin
    Gelbard, Sarah
    Bertrand, Martin
    Slater, Gary W.
    Figeys, Daniel
    Fai, Stephen
    Bennett, Steffany A. L.
    [J]. BIOINFORMATICS, 2013, 29 (02) : 284 - 285
  • [6] BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
  • [7] Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I α2 catalytic subunit
    Bonin, F
    Ryan, SD
    Migahed, L
    Mo, F
    Lallier, J
    Franks, DJ
    Arai, H
    Bennett, SAL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (50) : 52425 - 52436
  • [8] Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
    Buchhave, Peder
    Minthon, Lennart
    Zetterberg, Henrik
    Wallin, Asa K.
    Blennow, Kaj
    Hansson, Oskar
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2012, 69 (01) : 98 - 106
  • [9] Phospholipase A2 Biochemistry
    Burke, John E.
    Dennis, Edward A.
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) : 49 - 59
  • [10] Cerebrospinal Fluid Secretory Ca2+-Dependent Phospholipase A2 Activity Is Increased in Alzheimer Disease
    Chalbot, Sonia
    Zetterberg, Henrik
    Blennow, Kaj
    Fladby, Tormod
    Grundke-Iqbal, Inge
    Iqbal, Khalid
    [J]. CLINICAL CHEMISTRY, 2009, 55 (12) : 2171 - 2179